Kodiak Sciences Stock Buy Hold or Sell Recommendation
| KOD Stock | USD 3.64 0.19 5.51% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Kodiak Sciences is 'Cautious Hold'. Macroaxis provides Kodiak Sciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding KOD positions.
Check out Kodiak Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide. Note, we conduct extensive research on individual companies such as Kodiak and provide practical buy, sell, or hold advice based on investors' constraints. Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Kodiak |
Execute Kodiak Sciences Buy or Sell Advice
The Kodiak recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Kodiak Sciences. Macroaxis does not own or have any residual interests in Kodiak Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Kodiak Sciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Kodiak Sciences Trading Alerts and Improvement Suggestions
| Kodiak Sciences generated a negative expected return over the last 90 days | |
| Kodiak Sciences has high historical volatility and very poor performance | |
| Kodiak Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (260.49 M) with profit before taxes, overhead, and interest of 0. | |
| Kodiak Sciences has about 597.88 M in cash with (154.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.55, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Kodiak Sciences has a frail financial position based on the latest SEC disclosures | |
| Over 80.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: KOD Completes Enrollment in Phase III Study for Eye Disease Candidate |
Kodiak Sciences Returns Distribution Density
The distribution of Kodiak Sciences' historical returns is an attempt to chart the uncertainty of Kodiak Sciences' future price movements. The chart of the probability distribution of Kodiak Sciences daily returns describes the distribution of returns around its average expected value. We use Kodiak Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Kodiak Sciences returns is essential to provide solid investment advice for Kodiak Sciences.
| Mean Return | -0.9 | Value At Risk | -9.57 | Potential Upside | 9.24 | Standard Deviation | 7.08 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Kodiak Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Kodiak Stock Institutional Investors
| Shares | Geode Capital Management, Llc | 2024-12-31 | 768.7 K | Board Of Ttees Leland Stanford Jr Univ | 2024-12-31 | 691.8 K | Ikarian Capital, Llc | 2024-12-31 | 576.2 K | Point72 Asset Management, L.p. | 2024-12-31 | 523.8 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 521.2 K | Amvescap Plc. | 2024-12-31 | 519 K | Renaissance Technologies Corp | 2024-12-31 | 461.6 K | Jacobs Levy Equity Management, Inc. | 2024-12-31 | 360.5 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 339.2 K | Baker Bros Advisors Lp | 2024-12-31 | 17.3 M | Blackrock Inc | 2024-12-31 | 3.7 M |
Kodiak Sciences Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | 111.8M | 24.5M | (289.2M) | 249.2M | 286.6M | 300.9M | |
| Change In Cash | 738.8M | (212.9M) | (541.1M) | 95.1M | 85.6M | 89.8M | |
| Free Cash Flow | (90.4M) | (245.6M) | (253.8M) | (195.6M) | (176.0M) | (184.9M) | |
| Depreciation | 4.2M | 8.7M | 11.0M | 25.9M | 29.8M | 31.3M | |
| Other Non Cash Items | 49K | 53K | (1.6M) | (840K) | (756K) | (718.2K) | |
| Capital Expenditures | 7.0M | 63.3M | 47.4M | 41.4M | 47.6M | 50.0M | |
| Net Income | (133.1M) | (267.0M) | (333.8M) | (260.5M) | (234.4M) | (222.7M) | |
| End Period Cash Flow | 950.7M | 737.8M | 196.8M | 285.5M | 328.3M | 341.3M | |
| Change To Netincome | 6.1M | 30.7M | 61.5M | 105.4M | 121.2M | 127.3M |
Kodiak Sciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Kodiak Sciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Kodiak Sciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Kodiak stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.66 | |
β | Beta against Dow Jones | 1.79 | |
σ | Overall volatility | 6.06 | |
Ir | Information ratio | -0.11 |
Kodiak Sciences Volatility Alert
Kodiak Sciences is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Kodiak Sciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Kodiak Sciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Kodiak Sciences Fundamentals Vs Peers
Comparing Kodiak Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Kodiak Sciences' direct or indirect competition across all of the common fundamentals between Kodiak Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Kodiak Sciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Kodiak Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Kodiak Sciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Kodiak Sciences to competition |
| Fundamentals | Kodiak Sciences | Peer Average |
| Return On Equity | -0.79 | -0.31 |
| Return On Asset | -0.28 | -0.14 |
| Current Valuation | 75.54 M | 16.62 B |
| Shares Outstanding | 52.62 M | 571.82 M |
| Shares Owned By Insiders | 4.65 % | 10.09 % |
| Shares Owned By Institutions | 80.44 % | 39.21 % |
| Number Of Shares Shorted | 2.05 M | 4.71 M |
| Price To Earning | (2.29) X | 28.72 X |
| Price To Book | 1.08 X | 9.51 X |
| EBITDA | (259.02 M) | 3.9 B |
| Net Income | (260.49 M) | 570.98 M |
| Cash And Equivalents | 597.88 M | 2.7 B |
| Cash Per Share | 11.55 X | 5.01 X |
| Total Debt | 81.63 M | 5.32 B |
| Debt To Equity | 0.16 % | 48.70 % |
| Current Ratio | 8.65 X | 2.16 X |
| Book Value Per Share | 3.53 X | 1.93 K |
| Cash Flow From Operations | (154.18 M) | 971.22 M |
| Short Ratio | 6.70 X | 4.00 X |
| Earnings Per Share | (3.64) X | 3.12 X |
| Price To Earnings To Growth | (0.08) X | 4.89 X |
| Target Price | 6.67 | |
| Number Of Employees | 108 | 18.84 K |
| Beta | 2.26 | -0.15 |
| Market Capitalization | 181.55 M | 19.03 B |
| Total Asset | 479.37 M | 29.47 B |
| Retained Earnings | (1.15 B) | 9.33 B |
| Working Capital | 247.58 M | 1.48 B |
| Current Asset | 7.31 M | 9.34 B |
| Current Liabilities | 4.89 M | 7.9 B |
| Net Asset | 479.37 M |
Note: Acquisition by Borgeson John A. of 5494 shares of Kodiak Sciences subject to Rule 16b-3 [view details]
Kodiak Sciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Kodiak . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 13397.89 | |||
| Daily Balance Of Power | 0.9048 | |||
| Rate Of Daily Change | 1.06 | |||
| Day Median Price | 3.6 | |||
| Day Typical Price | 3.61 | |||
| Price Action Indicator | 0.14 | |||
| Period Momentum Indicator | 0.19 |
About Kodiak Sciences Buy or Sell Advice
When is the right time to buy or sell Kodiak Sciences? Buying financial instruments such as Kodiak Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Kodiak Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Theme ETFs Thematic Idea Now
Theme ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Theme ETFs theme has 480 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Theme ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Kodiak Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kodiak Sciences. If investors know Kodiak will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kodiak Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Kodiak Sciences is measured differently than its book value, which is the value of Kodiak that is recorded on the company's balance sheet. Investors also form their own opinion of Kodiak Sciences' value that differs from its market value or its book value, called intrinsic value, which is Kodiak Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kodiak Sciences' market value can be influenced by many factors that don't directly affect Kodiak Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kodiak Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kodiak Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kodiak Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.